1 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

2 Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

3 Certolizumab pegol for induction of remission in Crohn's disease

4 Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

5 Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

6 Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration

7 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

8 First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial

9 Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis

10 Vedolizumab for induction and maintenance of remission in ulcerative colitis

11 Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

12 Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

13 Comparative virulence of respiratory syncytial virus subgroups A and B

14 Vedolizumab as induction and maintenance therapy for ulcerative colitis

15 Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells

16 Defective regulation of immune responses in respiratory syncytial virus infection

17 intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade

18 immunotherapeutic advancements for glioblastoma

19 the humoral immune response to hcv: understanding is key to vaccine development

20 Results of the flow cytometry ACTG quality control program: analysis and findings

21 Deep remission in inflammatory bowel disease: looking beyond symptoms

22 Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

23 Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases

24 Adalimumab induces deep remission in patients with Crohn's disease

25 Hematopoietic activities of interleukin-1 alpha: in vitro and in vivo modulation by an anti-IL-1 receptor antibody

26 Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

27 [Investigation on the expression of microvessel pericyte coverage index and lymph vessel density in nasal polyps]

28 Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease

29 [Treatment of immune thrombocytopenia: a retrospective study of 40 patients]

30 Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed

31 Comparison of myosin heavy chains in atria and ventricles from hyperthyroid, hypothyroid, and euthyroid rabbits

32 Acidic and basic hair/nail ("hard") keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to "soft" keratins

33 p-155, a multimeric platelet protein that is expressed on activated platelets

34 Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

35 Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties

36 Erratum: Identification of a novel variant form of aspergillus fumigatus CalC and generation of Anti-CalC monoclonal antibodies (Medical Mycology Journal, (2019), 60, 1, (11-16), 10.3314/mmj.18-00013)

37 Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies

38 Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review.

39 Physicochemical stability of monoclonal antibodies: a review.

40 Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies

41 Highly Specific Monoclonal Antibody and Sensitive Quantum Dot Beads-Based Fluorescence Immunochromatographic Test Strip for Tebuconazole Assay in Agricultural Products.

42 Validation of monoclonal anti-PKC isozyme antibodies for flow cytometry analyses in human T cell subsets and expression in cord blood T cells

43 Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques- an experimental study.

44 Integration of Aqueous Two-Phase Extraction as Cell Harvest and Capture Operation in the Manufacturing Process of Monoclonal Antibodies.

45 Development and validation of monoclonal antibodies against N6-methyladenosine for the detection of RNA modifications.

46 An enhanced regeneration strategy to improve microbial control and prolong resin lifetime for Protein A resin in large-scale monoclonal antibody (mAb) purification.

47 Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration.

48 Differences for T-Cell Subtypes in Aspiration Biopsies of Patients With Kidney Transplant Under Polyclonal and Monoclonal Immunosuppressive Treatments.

49 Separation of monoclonal antibody charge variants using cation exchange chromatography: Resins and separation conditions optimization

50 Generation of Monoclonal Antibodies against Ag85A Antigen of Mycobacterium tuberculosis and Application in a Competitive ELISA for Serodiagnosis of Bovine Tuberculosis

51 A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.

52 Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

53 Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis.

54 Detection with a monoclonal antibody of a polysaccharide antigen, excreted in the urine, in the schistosomiasis intercalatum focus of edea (Cameroon)

55 Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

56 Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies.

57 Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

58 Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody

59 Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

60 Production of a specific monoclonal antibody for 1-naphthol based on novel hapten strategy and development of an easy-to-use ELISA in urine samples.

61 Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling.

62 Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.

63 Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (Nature Communications, (2020), 11, 1, (2251), 10.1038/s41467-020-16256-y)

64 A human monoclonal antibody blocking SARS-CoV-2 infection

65 Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies

66 Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

67 Evidence for monoclonal proliferation in prolymphocytic leukemia of T- cell origin

68 Serology of Mycobacteria: Characterization of Antigens Recognized by Monoclonal Antibodies

69 Preparation and Application of Yellow Fever Virus NS1 protein-specific Monoclonal Antibodies

70 Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

71 p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies

72 Humanised monoclonal antibody to respiratory syncytial virus

73 Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines

74 cd20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of cd20-positive raji cells

75 adverse events of monoclonal antibodies used for cancer therapy

76 efeito isolado do anticorpo monoclonal trastuzumab (herceptin®) em uma paciente com recidiva local de um carcinoma mamário com hiper-expressão de cerb-2

77 durvalumab: an investigational anti-pd-l1 monoclonal antibody for the treatment of urothelial carcinoma

78 in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections

79 fasinumab (regn475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

80 a monoclonal antibody recognizes undifferentiation-specific carbohydrate moieties expressed on cell surface of the human dental pulp cells

81 schistosoma mansoni: description of a potentially useful monoclonal antibody that recognizes soluble egg antigen (sea)

82 study of t-cell subsets, b and nk cells in iranian patients with behcet's disease by monoclonal antibodies

83 waldenstrom’s macroglobulinemia and peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes with a bleeding diathesis and rash

84 in vitro and in vivo pharmacology and pharmacokinetics of a human engineered™ monoclonal antibody to epithelial cell adhesion molecule

85 preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to n-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

86 evaluation of a monoclonal antibody affinity purified antigen for zymodeme specific serological diagnosis of trypanosoma cruzi infection

87 reversing egfr mediated immunoescape by targeted monoclonal antibody therapy

88 inhibition of p-selectin and psgl-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib

89 production of monoclonal antibodies against streptococcus mutans antigens produção de anticorpos monoclonais contra antígenos de streptococcus mutans

90 concomitant chronic myeloid leukemia and monoclonal b cell lymphocytosis - a very rare condition

91 the inhibitory effect of photodynamic therapy and of an anti-vcam-1 monoclonal antibody on the in vivo growth of c6 glioma xenografts

92 a case of severe asthma with eosinophilic otitis media successfully treated with anti-ige monoclonal antibody omalizumab

93 application of monoclonal antibodies against bioactive natural products: eastern blotting and preparation of knockout extract

94 preparation and partial characterization of monoclonal antibodies specific for the nascent non-triple helical form of the type iv collagen alpha 1 chain

95 proliferative glomerulonephritis with monoclonal immunoglobulin g lambda deposits: report of the first pediatric case

96 a monoclonal antibody to human dlk1 reveals differential expression in cancer and absence in healthy tissues

97 efficacy of urtoxazumab (tma-15 humanized monoclonal antibody specific for shiga toxin 2) against post-diarrheal neurological sequelae caused by escherichia coli o157:h7 infection in the neonatal gnotobiotic piglet model

98 a quantitative method for detecting ara h 2 by generation and utilization of monoclonal antibodies

99 primary endobronchial plasmacytoma involving local lymph nodes and presenting with rare immunoglobulin g lambda monoclonal gammopathy

100 new monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma

101 development of monoclonal antibodies in china: overview and prospects

Keyword Connections

Journals

Research Groups

Bibliographies